Interview with Dr Richard W Barker, Director General, Association of the British…
Taking a look at a key achievement of the ABPI in recent years, we recognize the role you played in negotiating the revised PPRS that was put in place last…
Address: 436 Cambridge Science Park
Milton Road
Cambridge
CB4 0QA
UK,United Kingdom
Tel: +44 (0)1223 226200
Web: http://astx.com/
Astex is the world leader in fragment based drug discovery – the most important advance in drug discovery chemistry in the last 20 years.
Our internal pipeline is currently focused on the discovery and development of products in the therapeutic areas of oncology and virology.
Our pre-eminent position in this field is underlined by:
The productivity of our discovery engine which has helped to deliver seven novel drug candidates into development – five of which are now in clinical trials with another two in preclinical development.
Multiple collaborations in various therapeutic areas with leading pharmaceutical companies such as AstraZeneca, GlaxoSmithKline, Janssen Pharmaceutica and Novartis that collectively have headline potential deal value in excess of $1 billion for Astex.
World-class science that has been published in leading journals such as Nature, Science and the Journal of Medicinal Chemistry, with some of our papers being among the most cited in their field.
Taking a look at a key achievement of the ABPI in recent years, we recognize the role you played in negotiating the revised PPRS that was put in place last…
It are exciting times for the UK, with the public healthcare system undergoing so many changes. The Office of Life Sciences (OLS) and the Therapeutic Capability Clusters are just some…
As part of a panel discussion with Claudia Hammond of the BBC last year, you commented on the fairly poor relationship between the NHS and industry, and the need to…
Together with Germany, the UK the highest generic penetration rate in Europe. Since you have been with the association since 1995 and obviously saw the great emergence of the generic…
Thank you for having us today! You have been chief executive of the Association since 1990 and obviously observed the evolution of the OTC market from close by. From your…
Given the heated debate over NHS reform and the new revised bill proposed by the government, what are you current priorities as President of the ABPI and how have these…
See our Cookie Privacy Policy Here